Protara Therapeutics, Inc. (TARA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.43
Day's range
$5.84

Protara Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JUPITER TOPCO LLC 08/14/2026 4.70 M $17.92 M   100.00% 7.70%
BLACKROCK, INC. 08/07/2026 3.66 M $13.99 M   7.91% 6.01%
MILLENNIUM MANAGEMENT LLC 08/14/2026 3.10 M $11.85 M   9.54% 5.08%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 2.84 M $10.87 M   0.35% 4.66%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.30 M $8.79 M   8.55% 3.77%
BLACKSTONE INC. 08/14/2026 2.27 M $8.65 M   0.00% 3.71%
ORBIMED ADVISORS LLC 08/14/2026 2.22 M $8.48 M   100.00% 3.64%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 1.92 M $7.34 M   -2.44% 3.15%
ACORN CAPITAL ADVISORS, LLC 08/14/2026 1.75 M $6.69 M   0.00% 2.87%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 08/14/2026 1.50 M $5.73 M   -14.29% 2.46%
5AM VENTURE MANAGEMENT, LLC 08/14/2026 1.37 M $5.23 M   0.00% 2.25%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.33 M $5.07 M   12.66% 2.17%
CITADEL ADVISORS LLC 09/02/2026 1.23 M $4.71 M   15.33% 2.02%
STATE STREET CORP 08/07/2026 1.07 M $4.08 M   6.28% 1.75%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.05 M $3.99 M   490.67% 1.71%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.03 M $3.92 M   100.00% 1.68%
BAKER BROS. ADVISORS LP 08/14/2026 971.61 K $3.71 M   0.00% 1.59%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 940.51 K $3.59 M   0.00% 1.54%
BANK OF AMERICA CORP /DE/ 08/14/2026 882.18 K $3.37 M   -4.72% 1.45%
MARSHALL WACE, LLP 08/13/2026 701.02 K $2.68 M   1,281.84% 1.15%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 683.23 K $2.61 M   28.60% 1.12%
NORTHERN TRUST CORP 08/13/2026 552.31 K $2.11 M   47.34% 0.91%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 548.93 K $2.10 M   -52.38% 0.90%
GOLDMAN SACHS GROUP INC 08/14/2026 546.23 K $2.09 M   37.25% 0.90%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 520.15 K $1.99 M   -10.32% 0.85%
MORGAN STANLEY 08/13/2026 508.43 K $1.94 M   -8.71% 0.83%
WALLEYE CAPITAL LLC 08/03/2026 505.43 K $1.93 M   13.99% 0.83%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 491.66 K $1.88 M   19.16% 0.81%
UBS GROUP AG 08/13/2026 456.77 K $1.74 M   -67.43% 0.75%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 334.68 K $1.28 M   8.37% 0.55%
VERDAD ADVISERS, LP 08/14/2026 312.25 K $1.19 M   100.00% 0.51%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 295.57 K $1.13 M   488.13% 0.48%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 251.50 K $960.73 K   100.08% 0.41%
OPPENHEIMER & CO INC 08/03/2026 238.36 K $910.54 K   31.28% 0.39%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 208.97 K $798.26 K   212.80% 0.34%
JUMP FINANCIAL, LLC 08/13/2026 203.10 K $775.84 K   204.14% 0.33%
CIBC WORLD MARKET INC. 08/13/2026 166.50 K $636.01 K   -5.13% 0.27%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 157.97 K $603.45 K   6.82% 0.26%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 157.97 K $603.45 K   100.00% 0.26%
BANK OF NEW YORK MELLON CORP 08/06/2026 137.69 K $525.97 K   6.18% 0.23%
J. GOLDMAN & CO LP 08/14/2026 135.00 K $515.70 K   -84.23% 0.22%
SUPERSTRING CAPITAL MANAGEMENT LP 08/14/2026 121.46 K $463.97 K   0.00% 0.20%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 99.57 K $380.34 K   100.00% 0.16%
AMERICAN CENTURY COMPANIES INC 08/12/2026 98.49 K $376.22 K   5.94% 0.16%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 85.33 K $325.96 K   21.33% 0.14%
NUVEEN, LLC 08/11/2026 72.61 K $277.37 K   13.70% 0.12%
TWO SIGMA INVESTMENTS, LP 08/14/2026 69.65 K $266.07 K   84.08% 0.11%
FMR LLC 08/13/2026 68.20 K $260.52 K   19.45% 0.11%
XTX TOPCO LTD 08/14/2026 63.95 K $244.28 K   8.75% 0.10%
RHUMBLINE ADVISERS 08/12/2026 63.25 K $241.59 K   97.18% 0.10%

Protara Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 151 institutional investors and hedge funds held shares of Protara Therapeutics Inc. The most heavily invested institutionals were:

Jupiter Topco LLC: 4.7 M

BlackRock, Inc.: 3.66 M

MILLENNIUM MANAGEMENT LLC: 3.1 M

Velan Capital Investment Management LP: 2.84 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.3 M

Blackstone Inc.: 2.27 M

75.79% of Protara Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 55.12 M shares in the last 24 months. This purchase volume represents approximately $316.96 M in transactions.